Epigenomics AG
Personalisation of medicine for cancer and other complex diseases; Development of novel diagnostics and pharmacodiagnostics
In June 2002, Alex Olek received the first German StartUp Award (Deutscher Gruenderpreis) established by the Sparkassen, McKinsey & Co. and Stern in order to promote entrepreneurialism in Germany.
Geert Nygaard (CEO)
Prof. Dr. Dr. Rolf Krebs (Chairman)
Prof. Dr. Dr. Uwe Bicker (Vice-Chairman)
Prof. Dr. Guenther Reiter
Dr. Ann Clare Kessler
Günther Frankenne
Heino von Prondzynski
Dr. Stefan Beck
Associate Prof. Susan Clark
Prof.Dr.med. Manfred Dietel
Prof. Andrew Feinberg
Dr. Jörg Hoheisel
Dr. Rudolf Jaenisch
Dr. Peter Jones
Dr. Peter Laird
Dr. Christoph Plass
Dr. Wolf Reik
Kleine Präsidentenstrasse 1
10178 Berlin
Germany
Phone: +49-30-24345-0
Fax: +49-30-24345-555
The datamining software Digital Phenotype® produces a digitised readout for each tissue on the basis of DNA methylation patterns.
Related patents
- Biochip reader with enhanced illumination and bioarray positioning apparatus
- Preparation method and use of micro-arrays supports for detection of multiple polynucleotide sequences with high sensitivity
- Method for producing complex DNA methylation fingerprints
- METHOD FOR PRODUCING COMPLEX DNA METHYLATION FINGERPRINTS
- Method for producing complex DNA methylation fingerprints
- Controlling performance of complex polymerase chain reaction amplification, useful e.g. for genotyping, using a set of many spec
- Method for identifying cytosine methylation patterns in genomic DNA
- Method for identifying cytosine methylation patterns in genomic DNA
- Use of fluorescent molecular beacons in the detection of methylated nucleic acids
- Photolithographic exposure unit for e.g. manufacturing DNA chips, scans target areas of biological material selectively with hig
- METHOD FOR RELATIVE QUANTIZATION OF METHYLATION OF CYTOSIN-TYPE BASES IN DNA SAMPLES
- Method for characterizing nucleic acid fragments
- NUCLEOSIDE DERIVATIVES AND A METHOD FOR PRODUCING THE SAME
- Determining the degree of cytosine methylation in genomic DNA, useful for diagnosis and prognosis, comprises selective hybridiza
- Controlling performance of complex polymerase chain reaction amplification, useful e.g. for genotyping, using a set of many spec
- Method for distinguishing 5-position methylation changes
- Fremgangsmåde til at skelne mellem methyleringsändringer i 5-stillingen
- Method for distinguishing 5-position methylation changes of cytosine bases and cytosine-to-thymine mutations
- Device and method for hybridizing double-stranded DNA samples on oligomer arrays
- Device and method for hybridizing double-stranded DNA samples on oligomer arrays
- Method for the controlled implementation of complex PCR amplifications
- METHOD FOR THE CONTROLLED IMPLEMENTATION OF COMPLEX PCR AMPLIFICATIONS
- Method for the parallel detection of the degree of methylation of genomic DNA
- METHOD FOR THE PARALLEL DETECTION OF THE DEGREE OF METHYLATION OF GENOMIC DNA
- Method for analyzing nucleic acid sequences
- Solid-phase synthesis of oligonucleotide array, useful e.g. for analyzing cytosine methylation patterns, comprises alternating a
- Contacting device
- Contacting device
- METHOD FOR DETECTING CYTOSINE METHYLATION IN DNA SAMPLES
- Ligase/polymerase method for detecting cytosine methylation in DNA samples
- METHOD FOR DETECTING CYTOSINE METHYLATION IN DNA SAMPLES
- Detection of variations in the DNA methylation profile
- METHOD FOR THE HIGHLY PARALLEL ANALYSIS OF POLYMORPHISMS
- METHOD FOR THE HIGH-PARALLEL ANALYSIS OF POLYMORPHISMS
- Method for detecting cytosine methylations
- DEVICE FOR PRODUCING OLIGOMER ARRAYS
- METHOD FOR DETERMINING THE AGE OF INDIVIDUALS
- METHOD FOR THE DETECTION OF CYTOSINE METHYLATIONS
- Detecting methylation status of test DNA in a mixture, useful for diagnosis and prognosis of disease, comprises bisulfite treatm
- METHOD FOR QUANTIFYING CYTOSINE METHYLATIONS IN GENOMIC DNA THAT IS AMPLIFIED IN A COMPLEX MANNER
- METHOD FOR THE SIMULTANEOUS AMPLIFICATION OF MULTIPLE SEQUENCES IN A PCR REACTION AND MARKING THEREOF
- Fluid delivery apparatus for loading dispensing tools
- METHODS, SYSTEMS AND COMPUTER PROGRAM PRODUCTS FOR DETERMINING THE BIOLOGICAL EFFECT AND/OR ACTIVITY OF DRUGS, CHEMICAL SUBSTANC
- Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status
- Detecting cytosine methylation in genomic DNA samples in which all unmethylated cytosine bases are converted to uracil and the 5
- Oligomer array with PNA and/or DNA oligomers on a surface
- A distributed system for epigenetic based prediciton of complex phenotypes
- Method and nucleic acids for the differentiation of prostate tumours
- METHOD FOR HIGH SENSITIVITY DETECTION OF CYTOSINE-METHYLATION
- Detection of specific dinucleotides in DNA-samples by fluorescence resonance energy transfer (FRET)
- Method for detecting cytosine methylation by comparatively analysing single strands of amplificates
- Distributed system for epigenetic based prediction of complex phenotypes
- Device and method for photolithographically irradiating biological substances
- Predicting responsiveness of a subject with breast cell proliferative disorder, useful for treating or differentiating breast ce
- METHOD FOR DETECTING DNA METHYLATION USING LABELLED S-ADENOSYLMETHIONINE ANALOGS
- METHOD FOR THE DETERMINATION OF CYTOSINE METHYLATION IN CPG ISLANDS
- METHOD FOR ANALYSIS OF GENOMIC METHYLATION MODELS
- METHOD FOR THE DETECTION OF CYTOSINE METHYLATION IN IMMOBILISED DNA SAMPLES
- Analysis of methylation patterns in a genomic DNA comprises amplification of a target DNA by a method that retains the methylati
- Method and integrated device for the detection of cytosine methylations
- METHOD FOR DETECTING CYTOSINE-METHYLATION PATTERNS BY EXPONENTIAL LIGATION OF HYBRIDISED PROBE OLIGO-NUCLEOTIDES (MLA)
- Method for the analysis of cytosine methylation patterns
- Method and nucleic acids for the analysis of colorectal cell proliferative disorders
- Method and nucleic acids for the analysis of a colon cell proliferative disorder
- Method and nucleic acids for the analysis of colon cell proliferative disorders
- METHOD FOR DETERMINING THE DEGREE OF METHYLATION OF DEFINED CYTOSINES IN GENOMIC DNA IN THE SEQUENCE CONTEXT 5 -CPG-3.
- Method and device for determination of tissue specificity of free floating DNA in bodily fluids
- Discovery and diagnostic methods using 5-methylcytosine DNA glycosylase
- Predicting responsiveness of a subject with breast cell proliferative disorder, useful for treating or differentiating breast ce
- METHOD FOR QUANTITATIVELY DETERMINING DEGREE OF METHYLATION OF CYTOSINE AT CpG POSITION
- Device for handling liquids contained in a pluralitz of channels
- METHOD FOR THE DETECTION OF NUCLEIC ACID SEQUENCES BY MEANS OF CRACKABLE PROBE MOLECULES
- Method for epigenetic feature selection
- Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxa
- Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxa
- Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxa
- Bisulfite conversion of DNA, involves reacting genomic DNA with bisulfite reagent, in presence of compound out of group of dioxa
- METHOD FOR MONITORING TRANSITION OF CELL FROM ONE STATE INTO ANOTHER STATE
- Systems, methods and computer program products for guiding selection of a therapeutic treatment regimen based on the methylation
- METHOD OF ANALYZING CYTOSIN METHYLATION STATUS OF CANCER-TESTIS-ANTIGENS FOR INDIVIDUALISED IMMUNETHERAPY
- Method and devices for dna methylation analysis
- Method for the analysis of methylation patterns within nucleic acids by means of mass spectrometry
- Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
- PROGNOSTIC MARKER FOR PREDICTING THERAPEUTIC RESPONSE AND/OR SURVIVAL PERIOD OF BREAST CELL PROLIFERATIVE DISORDER PATIENT
- PROGNOSIS DIAGNOSING MARKER FOR PREDICTING TREATMENT RESPONSE AND/OR SURVIVAL TIME OF PATIENT SUFFERING FROM MAMMARY CELL GROWTH
- Method and device for determination of tissue specificity of free floating dna in bodily fluids
- Method for quantification of methylated DNA
- Method of identifying cytosine methylation patterns in genomic DNA samples
- Use of fluorescent molecular beacons in the detection of methylated nucleic acids
- Method for the quantification of methylated DNA
Related news
- Epigenomics AG Enters into R&D Collaboration with Myriad Genetics Inc. to Discover DNA Methylation Biomarkers
- Epigenomics AG to Discover Biomarkers in R&D Collaboration with Centocor Inc.
- Epigenomics AG Reviews All Options for the Commercialization of Cancer Screening Test Products After End of Collaboration with Roche Diagnostics
- Epigenomics AG: PITX2 Prostate Cancer Molecular Classification Test Successfully Transferred to Affymetrix Diagnostic Platform
- Epigenomics AG Announces Research Collaboration with Stanford University
- Epigenomics AG Reports Financial Results for Fiscal Year 2005
- Epigenomics AG Reports Extension of Blood Screening Product Collaboration with Roche